[Medical treatment of essential arterial hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors; D007703:Peptidyl-Dipeptidase A / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D018377:Neurotransmitter Agents; D014665:Vasodilator Agents; D007703:Peptidyl-Dipeptidase A
Traitement médical de l'hypertension artérielle essentielle.